MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clove mediated Rescue in Parkinson’s Disease involves modulation of p53 and Sestrin2 in SHSY5Y cell line model

N. Rai, S. Dey (Udaipur, India)

Meeting: 2022 International Congress

Abstract Number: 1069

Keywords: Cell death, Neuroprotective agents, Paraquat

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: The study analyzed the neuroprotective effect of ethanolic extract of clove against Parkinson’s disease (PD) type toxicity in SHSY5Y cell line model and interrogation of underlying molecular mechanism.

Background: Although the exact causes of sporadic PD remain unclear, numerous environmental risk factors, especially neurotoxins, have been implicated in its aetiology.  The national Institute on Aging in the National Institutes of Health (NIH) has reported a common spice, clove with the highest ORAC (Oxygen Radical Absorbance Capacity) value. Clove stimulates nerves by pacifying Vata, one of the three aspects of healthy aging.

Method: The ethanolic extract of clove was prepared using the cold extraction process by crushing, soaking in ethanol, and stirred for 72 h followed by filtration and evaporation to remove complete ethanol. The PD type toxicity was induced with different concentrations of paraquat (PQ) in SH-SY5Y cells for 24, 48 and 72 h and cytotoxicity assessment was done by MTT assay. The rescue effect of clove from PQ induced toxicity was performed by simultaneous treatment of cells with 100μM PQ and different concentrations of clove followed by MTT assay. To elucidate the underlying mechanism, the protein expression analysis was performed using immunoblotting.

Results: The toxicity assay of PQ revealed considerable cell death in PQ-treated cells with maximum toxicity found at 72h. However, the clove treated cells were able to protect themselves from neuronal cell death upon exposure to PQ.  The rescue effect was mediated in a dose-dependent manner of clove. The immunoblot analysis revealed the elevated level of p53 and Setrin2 and phosphorylated AMPK (P-AMPK) (Thr172) in PQ treated SH-SY5Y cells in a dose-dependent manner. The levels of AMPK, mTOR, and p70S6K were unaltered. Interestingly, the phosphorylated p70S6K (P-p70S6K) (Thr389) decreased in a dose-dependent manner of PQ. However, upon simultaneous treatment of cells with 100 µM of PQ and increasing dose of clove, p53, Sesn2, and P-AMPK declined to the level of control. Also, the level of phosphorylated p70S6K (P-p70S6K) (Thr389) increased with an increasing dose of clove.

Conclusion: The present study reported that ethanolic extract of clove abrogated the PQ-induced cell death of SH-SY5Y by lowering the oxidative and ER stress and boosting the antioxidant system involving P53 and Sestrin2.

To cite this abstract in AMA style:

N. Rai, S. Dey. Clove mediated Rescue in Parkinson’s Disease involves modulation of p53 and Sestrin2 in SHSY5Y cell line model [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/clove-mediated-rescue-in-parkinsons-disease-involves-modulation-of-p53-and-sestrin2-in-shsy5y-cell-line-model/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clove-mediated-rescue-in-parkinsons-disease-involves-modulation-of-p53-and-sestrin2-in-shsy5y-cell-line-model/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley